Document Detail

Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.
MedLine Citation:
PMID:  18635689     Owner:  NLM     Status:  MEDLINE    
Gamma-hydroxybutyric acid (GHB) is a drug currently used for the treatment of alcohol dependence. The aim of our study was to investigate the incidence of craving for and abuse of GHB in 47 patients enrolled and divided into four groups: group A (pure alcoholics), group B (alcoholics with a sustained full remission from cocaine dependence), group C (alcoholics with a sustained full remission from heroin dependence) and group D (alcoholics in a methadone maintenance treatment [MMT] programme). All patients were treated with an oral dose of GHB (50 mg/kg of body weight t.i.d.) for three months. Craving for GHB was statistically significant higher in group B than in group A (P < 0.001), C (P = 0.01) and D (P < 0.001), and in group C than in group D (P < 0.05). Abuse of GHB proved to be statistically significant higher in group B than in group A (P < 0.001) and D (P < 0.01), and in group C than in group A (P = 0.01) and D (P < 0.05). Thus, the administration of GHB in alcoholics with a sustained full remission from heroin or cocaine dependence is not recommended; however, this should not discourage physicians from using GHB for the treatment of pure alcoholics or alcohol dependents following a MMT.
F Caputo; S Francini; M Stoppo; F Lorenzini; T Vignoli; A Del Re; C Comaschi; L Leggio; G Addolorato; G Zoli; M Bernardi
Related Documents :
24972739 - Selective double disconnection for cirrhotic portal hypertension.
24326659 - Superior masenteric vein thrombosis.
24044439 - Left endobronchial intubation with a double-lumen tube using direct laryngoscopy or the...
22304449 - A novel technique of multiple-site epidural blood patch administration for the treatmen...
23679029 - Dynamic esophageal stents.
23169569 - Nasal backflow and the difficulty of relaxation in the upper esophageal sphincter.
20079159 - Initial experiences of maintaining atrioventricular intrinsic conduction during cardiac...
1867239 - Hepatosplenic candidiasis: successful treatment with fluconazole.
19008239 - Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardia...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-07-17
Journal Detail:
Title:  Journal of psychopharmacology (Oxford, England)     Volume:  23     ISSN:  1461-7285     ISO Abbreviation:  J. Psychopharmacol. (Oxford)     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-06     Completed Date:  2010-01-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907828     Medline TA:  J Psychopharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  883-90     Citation Subset:  IM    
G. Fontana Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alcoholism / drug therapy*
Hydroxybutyrates / adverse effects*
Middle Aged
Substance-Related Disorders / etiology*
Reg. No./Substance:
0/Hydroxybutyrates; 591-81-1/4-hydroxybutyric acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and act...
Next Document:  Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active...